About AL Amyloidosis AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that build-up in the heart, kidney, and liver, causing heart and ...
On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis –Los ...
MaxWell Clinic has performed plasma exchange since 2018 and serves patients who travel from across the United States to Nashville for consultation and care. Patients and caregivers can learn more ...
NASHVILLE, TN / ACCESS Newswire / September 19, 2025 / In recognition of World Alzheimer's Day on September 21, MaxWell Clinic today announced that it is entering its eighth year of offering a ...
The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.
The world's largest crypto exchange platform by trading volume is adding support for a new layer-1 blockchain focused on ...
American Journal of Transplantation study positions GraftAssure as potentially essential in managing immunosuppression treatment in kidney ...
Oral therapy tied to increased cardiovascular risk but not for estrogen-sensitive cancers. (HealthDay News) — Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback